Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Differentiation-dependent doxorubicin toxicity on h9c2 cardiomyoblasts
Ana F. Branco
, Susana F. Sampaio
, Ana C. Moreira
, Jon Holy
, Kendall B. Wallace
, Ines Baldeiras
, Paulo J. Oliveira
, Vilma A. Sardão
Biomedical Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
45
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Differentiation-dependent doxorubicin toxicity on h9c2 cardiomyoblasts'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Doxorubicin
100%
H9c2 Cardiomyocytes
100%
Doxorubicin Toxicity
100%
Cytotoxicity
40%
Muscle Cells
40%
Cardiac Toxicity
40%
Differentiation Stage
40%
Persistent Toxicity
40%
Skeletal muscle
20%
Cell Proliferation
20%
Cardiotoxicity
20%
Childhood Cancer Survivors
20%
Early childhood
20%
Stress Response
20%
Cardiac muscle
20%
Anthracyclines
20%
Cardiac Development
20%
Cardiac Progenitor Cells
20%
Cardiac Failure
20%
Differentiated Cells
20%
Bcl-xL
20%
Anti-apoptotic Proteins
20%
H9c2
20%
H9c2 Myoblasts
20%
Mitochondrial Superoxide Dismutase
20%
Muscle Markers
20%
Embryonic Cell Line
20%
Delayed Toxicity
20%
Characteristic Component
20%
Muscle Phenotype
20%
H9c2 Cell Differentiation
20%
Toxicity Persistence
20%
Differentiated H9c2 Cells
20%
Differentiation State
20%
Doxorubicin Chemotherapy
20%
Antineoplastic
20%
Medicine and Dentistry
Doxorubicin
100%
Cardiotoxicity
33%
Myocyte
22%
Cell Line
22%
Cytotoxicity
22%
Anticarcinogen
11%
Protein P53
11%
Childhood Cancer
11%
Cardiac Muscle
11%
Cell Differentiation
11%
Cell Proliferation
11%
Congestive Heart Failure
11%
Superoxide Dismutase
11%
Heart Development
11%
Antiapoptotic
11%
Bcl-xL
11%
Anthracycline
11%
Progenitor Cell
11%
Myoblast
11%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Cardiotoxicity
22%
Cytotoxicity
22%
Antiapoptotic
11%
Anticarcinogen
11%
Protein P53
11%
Congestive Heart Failure
11%
Superoxide Dismutase
11%
Childhood Cancer
11%
Anthracycline
11%
Rat
11%
Biochemistry, Genetics and Molecular Biology
Doxorubicin
100%
Cytotoxicity
22%
Cellular Differentiation
11%
Cell Proliferation
11%
Bcl-xL
11%
Superoxide Dismutase
11%
P53
11%
Progenitor Cell
11%
Anthracycline
11%
Rat
11%
Cell Differentiation
11%